Target intelligence / Profile preview

Membrane immunoglobulin M (mIgM) (mIgM)

Target
mIgM
Molecular classification
Receptor, B cell antigen receptor, Immunoglobulin
01

Overview

Membrane immunoglobulin M (mIgM), also known as the B cell antigen receptor (BCR), is the monomeric form of IgM expressed on the surface of naïve and immature B lymphocytes. It consists of two μ heavy chains (each with four constant domains: Cμ1-Cμ4, plus a transmembrane tailpiece) and two light chains (kappa or lambda), linked by disulfide bonds and non-covalent interactions. The μ heavy chain has an additional hydrophobic transmembrane domain (about 41 amino acids) for anchoring to the B cell membrane. As a BCR, mIgM recognizes antigens with high specificity via its variable domains, initiating B cell signaling, activation, proliferation, and differentiation into plasma cells or memory B cells. It plays a key role in primary immune responses, self/non-self discrimination, and B cell development. Unlike secreted pentameric IgM (sIgM), mIgM does not incorporate a J-chain and functions primarily in antigen detection rather than secretion or mucosal transport.

Other names
membrane-bound IgMmonomeric IgMB cell receptor (BCR)membrane IgMsurface IgM
02

Biological functions

Antigen recognitionSignal transductionB cell activationPrimary immune response initiationHomeostasis (clearance of apoptotic cells and debris)Complement activationOpsonizationPhagocytosis recruitment
03

Disease associations

InfectionAutoimmunityAllergic diseasesCancer (B cell related)Inflammation

Beyond the preview

Go deeper on Membrane immunoglobulin M (mIgM) (mIgM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane immunoglobulin M (mIgM) (mIgM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call